DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BOSULIF

See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Bosulif

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02228382	Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors	Recruiting	Developmental Therapeutics Consortium	Phase 4	2014-11-01	The purpose of this study is to fulfill the post-authorization commitment made by Pfizer to the European Medicines Agency in providing additional safety and efficacy data in approximately 150 Philadelphia Chromosome Positive Chronic Myeloid Leukemia patients with high unmet medical need, including 75 Chronic Phase, Accelerated Phase or Blast Phase patients in the fourth or later line treatment setting (i.e., after treatment with at least 3 other Tyrosine Kinase Inhibitors).
NCT02228382	Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors	Recruiting	Pfizer	Phase 4	2014-11-01	The purpose of this study is to fulfill the post-authorization commitment made by Pfizer to the European Medicines Agency in providing additional safety and efficacy data in approximately 150 Philadelphia Chromosome Positive Chronic Myeloid Leukemia patients with high unmet medical need, including 75 Chronic Phase, Accelerated Phase or Blast Phase patients in the fourth or later line treatment setting (i.e., after treatment with at least 3 other Tyrosine Kinase Inhibitors).
NCT02501330	Safety And Efficacy Of Bosutinib	Active, not recruiting	Pfizer	N/A	2015-07-01	The objective of this surveillance is to collect information about 1. adverse drug reaction not expected from the LPD (unknown adverse drug reaction) 2. the incidence of adverse drug reactions in this surveillance 3. factors considered to affect the safety and/or efficacy of this drug.

Clinical Trial Conditions for Bosulif

Condition Name

Condition Name for Bosulif
Intervention	Trials
Multiple Myeloma	1
Advanced Solid Tumors	1
Dementia With Lewy Bodies	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Bosulif
Intervention	Trials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive	4
Leukemia, Myeloid	4
Dementia	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Bosulif

Trials by Country

Trials by Country for Bosulif
Location	Trials
United States	22
Italy	11
Spain	3
Austria	2
United Kingdom	2

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Bosulif
Location	Trials
Washington	2
California	2
District of Columbia	2
Michigan	2
Pennsylvania	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Bosulif

Clinical Trial Phase

Clinical Trial Phase for Bosulif
Clinical Trial Phase	Trials
Phase 4	1
Phase 2	3
Phase 1	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Bosulif
Clinical Trial Phase	Trials
Recruiting	4
Active, not recruiting	2
Enrolling by invitation	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Bosulif

Sponsor Name

Sponsor Name for Bosulif
Sponsor	Trials
Pfizer	6
Georgetown University	2
Alzheimer's Association	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Bosulif
Sponsor	Trials
Industry	12
Other	9

Export unavailable in trial.
Subscribe for complete access.